Department of Cardiac Surgery, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Harvard Medical School, Boston, Mass; Department of Cardiology, Boston Children's Hospital, Boston, Mass.
J Thorac Cardiovasc Surg. 2022 Dec;164(6):1980-1990.e7. doi: 10.1016/j.jtcvs.2022.01.049. Epub 2022 Mar 11.
To determine the contemporary outcomes of the double switch operation (DSO) (ie, Mustard or Senning + arterial switch).
A single-institution, retrospective review of all patients with congenitally corrected transposition of the great arteries undergoing a DSO.
Between 1999 and 2019, 103 patients underwent DSO with a Mustard (n = 93) or Senning (n = 10) procedure. Segmental anatomy was (S, L, L) in 93 patients and (I, D, D) in 6 patients. Eight patients had heterotaxy and 71 patients had a ventricular septal defect. Median age was 2.1 years (range, 1.8 months-40 years), including 34 patients younger than age 1 year (33%). Median weight was 10.9 kg (range, 3.4-64 kg). Sixty-one patients had prior pulmonary artery bands for a median of 1.1 years (range, 14 days-12.9 years; interquartile range, 0.7-3.1 years). Median intensive care unit and hospital lengths of stay were 5 and 10 days, respectively. Median follow-up was 3.4 years (interquartile range, 1-9.8 years) and 5.2 years (interquartile range, 2.3-10.7 years) in 79 patients with >1 year follow-up. At latest follow-up, aortic, mitral, tricuspid valve regurgitation, and left ventricle dysfunction was less than moderate in 96%, 98%, 96%, and 93%, respectively. Seventeen patients underwent reoperation: neoaortic valve intervention (n = 10), baffle revision (n = 5), and ventricular septal defect closure (n = 4). At latest follow-up, 17 patients (17%) had a pacemaker and 27 (26%) had cardiac resynchronization therapy devices. There were 2 deaths and 2 transplants. Transplant-free survival was 94.6% at 5 years. Risk factors for death or transplant included longer cardiopulmonary bypass time and older age at DSO.
The outcomes of the DSO are promising. Earlier age at operation might favor better outcomes. Progressive neoaortic regurgitation and reinterventions on the neo-aortic valve are anticipated problems.
确定双调转手术(DSO)(即 Mustard 或 Senning 术+动脉调转术)的当代结果。
这是一项单中心回顾性研究,纳入了所有接受 DSO 的先天性矫正性大动脉转位患者。
1999 年至 2019 年间,共有 103 例患者接受了 DSO,其中 93 例接受了 Mustard 手术,10 例接受了 Senning 手术。93 例患者的节段解剖为(S,L,L),6 例患者为(I,D,D)。8 例患者存在心脏异位,71 例患者存在室间隔缺损。中位年龄为 2.1 岁(范围,1.8 个月-40 岁),包括 34 例年龄小于 1 岁(33%)的患者。中位体重为 10.9kg(范围,3.4-64kg)。61 例患者曾行肺动脉带环术,中位时间为 1.1 年(范围,14 天-12.9 年;四分位距,0.7-3.1 年)。中位重症监护病房和住院时间分别为 5 天和 10 天。79 例患者随访时间超过 1 年,中位随访时间为 3.4 年(四分位距,1-9.8 年),5.2 年(四分位距,2.3-10.7 年)。末次随访时,主动脉瓣、二尖瓣、三尖瓣反流及左心室功能不全程度均小于中度的比例分别为 96%、98%、96%和 93%。17 例患者接受了再次手术:行新主动脉瓣干预(n=10)、心内补片修正(n=5)和室间隔缺损修补(n=4)。末次随访时,17 例(17%)患者需安置起搏器,27 例(26%)患者需心脏再同步治疗。2 例患者死亡,2 例患者接受心脏移植。5 年时无移植生存率为 94.6%。死亡或移植的危险因素包括体外循环时间较长和 DSO 时年龄较大。
DSO 的结果很有前景。手术时年龄较小可能会获得更好的结果。新主动脉瓣的进行性反流和再干预是预期的问题。